Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
No serious adverse events, liver enzyme elevations, or cardiovascular changes were documented in the 12-week Phase 1 safety study
The carboxyl-terminal fragment of hGH corresponding to amino acids 177191 (AOD9604) was shown to act as a lipid mobilizing domain with inhibitory action on acetyl-CoA carboxylase (ACC) activity in hepatocytes and adipocytes
Skinny shot side effects are typically mild and short-lived
NNMT inhibition increases intracellular NAD+ by blocking nicotinamide methylation, but the long-term metabolic consequences of sustained NNMT suppression
Preclinical data suggests AOD9604 shifts the metabolic balance toward burning fatty acids for energy rather than storing them, with effects observed particularly in visceral adipose tissue
